Aboulafia, D.M., Bundow, D., Waide, S., et al. (2000). Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia. The American Journal of the Medical Sciences, 320, 117–123.

American Academy of Pediatrics, Task Force on Pediatric AIDS. (1988). Pediatric guidelines for infection control of human immunodeficiency virus (acquired immunodeficiency virus) in hospitals, medical offices, schools, and other settings. Pediatrics, 82, 801–807.

Americans with Disabilities Act (ADA) of 1990, PL 101-336, 42 U.S.C. §§ 12101 et seq.

Angelini, L., Zibordi, F., Triulzi, F., et al. (2000). Age-dependent neurologic manifestations of HIV infection in childhood. Neurological Sciences, 21, 135–142.

Arendt, G., von Giesen, H.J., Hefter, H., et al. (2001). Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection. AIDS, 15, 493–500.

Arpadi, S.M. (2000). Growth failure in children with HIV infection. Journal of Acquired Immune Deficiency Syndrome, 25(Suppl. 1), S37–S42.

Barnhart, H.X., Caldwell, M.B., Thomas, P., et al. (1996). Natural history of human immunodeficiency virus disease in perinatally infected children: An analysis from the Pediatric Spectrum of Disease Project. Pediatrics, 97, 710–716.

Beisel, W.R. (1996). Nutrition in pediatric HIV infection: Setting the research agenda. Nutrition and immune function: Overview. Journal of Nutrition, 126(Suppl.), 2611S–2615S.

Berkelhamer, S., Borock, E., Elsen, C., et al. (2001). Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children. Clinical Infectious Diseases, 32, 1090–1094.

Brook, M.G., & Miller, R.F. (2001). HIV associated nephropathy: A treatable condition. Sexually Transmitted Infections, 77, 97–100.

Brown, L.K., Lourie, K.J., & Pao, M. (2000). Children and adolescents living with HIV and AIDS: A review. Journal of Child Psychology and Psychiatry and Allied Disciplines, 41, 81–96.

Burroughs, M.H., & Edelson, P.J. (1991). Medical care of the HIV-infected child. Pediatric Clinics of North America, 38, 45–67.

Butler, K.M., Husson, R.N., Balis, F.M., et al. (1991). Dideoxyinosine in children with symptomatic human immunodeficiency virus. New England Journal of Medicine, 324, 137–144.

Cause-specific adult mortality: Evidence from community-based surveillance—selected sites, Tanzania, 1992–1998. (2000). MMWR, 49, 416–419.

Centers for Disease Control and Prevention (CDC). (1994). 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR, 43(No. RR-12), 1–10.

Centers for Disease Control and Prevention (CDC). (1998). Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR, 47(No. RR-4), 1–38. (See http://www.hivatis.org/trtgdlns.html#Pediatric for most recent guidelines.)

Chase, C., Ware, J., Hittelman, J., et al. (2000). Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group. Pediatrics, 106, E25.

Chesney, M.A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30(1, Suppl. 2), S171–S176.

Clavel, F., Guetard, D., Brun-Vezinet, F., et al. (1986). Isolation of a new human retrovirus from West African patients with AIDS. Science, 233, 343–346.

Cock, K.M., & H.A. Weiss. (2000). The global epidemiology of HIV/AIDS. Tropical Medicine and International Health, 5(7), A3–A9.

Cooper, E.R., Hanson, C., Diaz, C., et al. (1998). Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group. Journal of Pediatrics, 132, 808–812.

Coplan, J., Contello, K.A., Cunningham, C.K., et al. (1998). Early language development in children exposed to or infected with human immunodeficiency virus. Pediatrics, 102, e8.

Davis-McFarland, E. (2000). Language and oral-motor development and disorders in infants and young toddlers with human immunodeficiency virus. Seminars in Speech and Language, 21, 19–34; quiz 34–35.

Dellow, E., Unwin, R., Miller, R., et al. (1999). Protease inhibitor therapy for HIV infection: The effect on HIV-associated nephrotic syndrome. Nephrology, Dialysis, Transplantation, 14, 744–747.

Dominguez, K.L. (2000). Management of HIV-infected children in the home and institutional settings. Care of children and infections control in schools, day care, hospital settings, home, foster care, and adoption. Pediatric Clinics of North America, 47, 203–239.

Dunn, D.T., Brandt, C.D., Krivine, A., et al. (1995). The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS, 9, F7–F11.

Feingold, A.R., Rutstein, R.M., Meislich, D., et al. (2000). Protease inhibitor therapy in HIV-infected children. AIDS Patient Care and STDs, 14, 589–593.

Fletcher, C.V. (1992). Treatment of herpes virus infections in HIV-infected individuals. Annals of Pharmacotherapy, 26, 955–962.

Fowler, M.G. (1994). Pediatric HIV infection: Neurological and neuropsychologic findings. Acta Paediatrica, 400(Suppl.), 59–62.

Gao, F., Bailes, E., Robertson, D.L., et al. (1999). Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature, 397, 436–441.

Gay, C.L., Armstrong, F.D., Cohen, D., et al. (1995). The effects of HIV on cognitive and motor development in children born to HIV-seropositive women with no reported drug use: Birth to 24 months. Pediatrics, 96, 1078–1082.

Gewirtz, A., & Gossart-Walker, S. (2000). Home-based treatment for children and families affected by HIV and AIDS. Dealing with stigma, secrecy, disclosure, and loss. Child and Adolescent Psychiatric Clinics of North America, 9, 313–330.

Gortmaker, S., Hughes, M., Oyomopito, R., et al. (2000). Impact of introduction of protease inhibitor therapy on reductions in mortality among children and youth infected with HIV-1 (Abstract 691). Seventh Conference on Retroviruses and Opportunistic Infections, San Francisco.

Grubman, S., Gross, E., Lerner-Weiss, N., et al. (1995). Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics, 95, 657–663.

Hauger, S.B., & Powell, K.R. (1990). Infectious complications in children with HIV infection. Pediatric Annals, 19, 421–436.

Ho, D.D., Neumann, A.U., Perelson, A.S., et al. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373, 123–126.

Individuals with Disabilities Education Act Amendments of 1997, PL 105-17, 20 U.S.C. §§ 1400 et seq.

Instone, S.L. (2000). Perceptions of children with HIV infection when not told for so long: Implications for diagnosis disclosure. Journal of Pediatric Health Care, 14, 235–243.

Jaquet, D., Levine, M., Ortega-Rodriguez, E., et al. (2000). Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS, 14, 2123–2128.

Johnson, C.B. (1993). Developmental issues: Children infected with the human immunodeficiency virus. Journal of Infants and Young Children, 6, 1–10.

Kaplan, J.E., Hanson, D., Dworkin, M.S., et al. (2000). Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 30(5, Suppl. 1), S5–S14.

Knight, W.G., Mellins, C.A., Levenson, R.L., et al. (2000). Effects of pediatric HIV infection on mental and psychomotor development. Journal of Pediatric Psychology, 25(8), 583–587.

Korber, B., Muldoon, M., Theiler, J., et al. (2000). Timing the ancestor of the HIV-1 pandemic strains. Science, 288, 1789–1796.

Krener, P., & Miller, F.B. (1989). Psychiatric response to HIV spectrum disease in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 596–605.

Langston, C., Cooper, E.R., Goldfarb, J., et al. (2001). Human immunodeficiency virus-related mortality in infants and children: Data from the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV (P(2)C(2)) Study. Pediatrics, 107, 328–338.

Laurence, J. (2001). Adhering to antiretroviral therapies. AIDS Patient Care and STDs, 15, 107–108.

Layton, T.L., & Scott, G.S. (2000). Language development and assessment in children with human immunodeficiency virus: 3 to 6 years. Seminars in Speech and Language, 21, 37–46; quiz 46–47.

Li, Q., Tsang, B., Ding, L., et al. (1998). Infection with the human immunodeficiency virus type 2: Epidemiology and transmission (Review). International Journal of Molecular Medicine, 2, 573–576.

Lindegren, M.L., Steinberg, S., & Byers, R.H. (2000). Epidemiology of HIV/AIDS in children. Pediatric Clinics of North America, 47, 1–20, v.

Luo, C. (2000). Achievable standard of care in low-resource settings. Annals of the New York Academy of Sciences, 918(4), 179–187.

Luzuriaga, K., & Sullivan, J.L. (2000). Viral and immunopathogenesis of vertical HIV-1 infection. Pediatric Clinics of North America, 47, 65–78.

Miller, T.L. (2000). Nutrition in paediatric human immunodeficiency virus infection. The Proceedings of the Nutrition Society, 59, 155–162.

Miller, T.L., Awnetwant, E.L., Evans, S., et al. (1995). Gastrostomy tube supplementation for HIV-infected children. Pediatrics, 96, 696–702.

Mok, J., & Newell, M.L. (Eds.). (1995). HIV infection in children: A guide to practical management. New York: Cambridge University Press.

Mueller, B.U., & Pizzo, P.A. (1992). Medical treatment of children with HIV infection. In A.C. Crocker, H.J. Cohen, & T.A. Kastner (Eds.), HIV infection and developmental disabilities: A resource for service providers (pp. 63–73). Baltimore: Paul H. Brookes Publishing Co.

Myhre, J.A., Chadwick, E.G., & Yogev, R. (1996). Failure to thrive in HIV-infected children: Incidence, prevalence, and clinical correlates. Pediatric AIDS and HIV Infection, 7, 83–90.

Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study. (1994). Pediatrics, 94, 815–819.

Nehring, W.M., Lashley, F.R., & Malm, K. (2000). Disclosing the diagnosis of pediatric HIV infection: Mothers’ views. Journal of the Society of Pediatric Nurses, 5, 5–14.

Oleske, J.M. (1994). The many needs of the HIV-infected child. Hospital Practice (Office Edition), 29, 81–87.

Onorato, I.M., Markowitz, L.E., & Oxtoby, M.J. (1988). Childhood immunization, vaccine-preventable diseases and infection with human immunodeficiency virus. The Pediatric Infectious Disease Journal, 7, 588–595.

Perelson, A.S., Neumann, A.U., Markowitz, M., et al. (1996). HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science, 271, 1582–1586.

Persaud, D., Pierson, T., Ruff, C., et al. (2000). A stable latent reservoir for HIV-1 in resting CD41 T lymphocytes in infected children. The Journal of Clinical Investigation, 105, 995–1003.

Pictet, G., Le Coeur, S., M’Pele, P., et al. (1998). Contribution of AIDS to the general mortality in Central Africa: Evidence from a morgue-based study in Brazzaville, Congo. AIDS, 12, 2217–2223.

Pilowsky, D.J., Lyles, C.M., Cross, S.I., et al. (2001). Characteristics of injection drug using parents who retain their children. Drug and Alcohol Dependence, 61, 113–122.

Pizzo, P.A., & Wilfert, C.M. (1999). Pediatric AIDS: The challenge of HIV infection in infants, children, and adolescents (3rd. ed.). Philadelphia: Lippincott Williams & Wilkins.

Pugliese, A., Isnardi, D., Saini, A., et al. (2000). Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. The Journal of Infection, 40, 282–284.

Reddington, C., Cohen, J., Baldillo, A., et al. (2000). Adherence to medication regimens among children with human immunodeficiency virus infection. The Pediatric Infectious Disease Journal, 19, 1148–1153.

Rosenfeldt, V., Valerius, N.H., & Paerregaard, A. (2000). Regression of HIV-associated progressive encephalopathy of childhood during HAART. Scandinavian Journal of Infectious Diseases, 32, 571–574.

Ryan White CARE Act Amendments of 2000, PL 106-345, 42 U.S.C. §§ 201 et seq.

Sacktor, N., Lyles, R.H., Skolasky, R., et al. (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology, 56, 257–260.

Salisbury, K.M. (2000). National and state policies influencing the care of children affected by AIDS. Child and Adolescent Psychiatric Clinics of North America, 9(2), 425–449.

Schwartlaender, B., Garnett, G., Walker, N., et al. (2000). AIDS in a new millennium. Science, 289, 64–66.

Semba, R.D., Shah, N., & Vlahov, D. (2001). Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 26, 315–319.

Simonds, R.J., & Rogers, M.F. (1992). Epidemiology of HIV infection in children and other populations. In A.C. Crocker, H.J. Cohen, & T.A. Kastner (Eds.), HIV infection and developmental disabilities: A resource for service providers (pp. 3–13). Baltimore: Paul H. Brookes Publishing Co.

Spector, S.A., Busch, D.F., Follansbee, S., et al. (1995). Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: A phase I/II study. AIDS Clinical Trials Group and Cytomegaolvirus Cooperative Study Group. Journal of Infectious Diseases, 171, 1431–1437.

Spiegel, H., & Mayers, A. (1991). Psychosocial aspects of AIDS in children and adolescents. Pediatric Clinics of North America, 38, 153–167.

Spira, R., Lepage, P., Msellati, P., et al. (1999). Natural history of human immunodeficiency virus type 1 infection in children: A five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics, 104, e56.

Suarez, S., Baril, L., Stankoff, B., et al. (2001). Outcome of patients with HIV-1–related cognitive impairment on highly active antiretroviral therapy. AIDS, 15, 195–200.

Suarez, S.V., Stankoff, B., Conquy, L., et al. (2000). Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia. European Journal of Neurology, 7, 151–158.

Tasker, S.A., & Wallace, M.R. (2000). Vaccination in HIV-infected Patients. Current Infectious Diseases Reports, 2, 245–256.

Taylor-Brown, S., & Garcia, A. (1995). Social workers and HIV-affected families: Is the profession prepared? Social Work, 40, 14–15.

Taylor-Brown, S., & Kumetat, S. H. (1994). Psychosocial aspects of pediatric human immunodeficiency virus and acquired immunodeficiency syndrome: Annotated literature review and call for research. Journal of Developmental and Behavioral Pediatrics, 15, S71–S76.

Taylor-Brown, S., Teeter, J.A., Blackburn, E., et al. (1998). Parental loss due to HIV: Caring for children as a community issue—the Rochester, New York experience. Child Welfare, 77, 137–160.

Tepper, V.J., Farley, J.J., Rothman, M.I., et al. (1998). Neurodevelopmental/neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir. Pediatrics, 101, e7.

Trad, P.V., Kentros, M., Solomon, G.E., et al. (1994). Assessment and psychotherapeutic intervention for an HIV-infected preschool child. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 1338–1345.

Tudor-Williams, G. (2000). HIV infection in children in developing countries. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 3–4.

Viani, R.M., Dankner, W.M., Muelenaer, P.A., et al. (1999). Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube. Pediatrics, 104, 1394–1396.

Watson, D.C., & Farley, J.J. (1999). Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. The Pediatric Infectious Disease Journal, 18, 682–689.

Woodruff, G., Driscoll, P., & Sterzin, E.D. (1992). Providing comprehensive and coordinated services to children with HIV infection and their families: A transagency model. In A.C. Crocker, H.J. Cohen, & T.A. Kastner (Eds.), HIV infection and developmental disabilities: A resource for service providers (pp. 105–112). Baltimore: Paul H. Brookes Publishing Co.